Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advil in Men With Elevated Serum PSA
NCT05512754Phase 4
Key facts
- Status
- Recruiting
- Start
- Aug 2022
- Primary completion
- Dec 2027
- Countries
- 1
- Sponsor
- University of Chicago
- Modality
- Small Molecules
- Drugs
- ibuprofen
01
Overview
Phase 4, randomised, open-label trial of ibuprofen, sponsored by University of Chicago. Primary endpoint: Prostate-specific antigen at 6 weeks. Started Aug 2022; status: recruiting.
02
Design
- Study design
- RandomizedOpen-label
03
Endpoints
Primary
Prostate-specific antigen
Beyond the preview
Go deeper on NCT05512754.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05512754.